Regulatory Updates
Aug 30, 2026•1 min read
MHRA March 2024 Letters and Medicine Recalls Summary
A brief overview of letters and notifications sent to UK healthcare professionals about medicines and medical devices in March 2024.
Regulatory Updates
Aug 27, 2026•1 min read
MHRA flags increased wear and corrosion risk in cobalt‑chrome modular neck hip stems
The UK Medicines and Healthcare products Regulatory Agency (MHRA) reports higher wear, corrosion and possible revision surgery risks for cobalt‑chrome modular neck hip stem components.
Regulatory Updates
Aug 25, 2026•1 min read
MHRA Issues Reminder on Neuropsychiatric Risks of Montelukast
MHRA reminds prescribers that montelukast can cause neuropsychiatric reactions, including sleep disorders, in patients of all ages.
Regulatory Updates
Aug 25, 2026•1 min read
MHRA Issues April 2024 Update on Medicines and Device Safety Communications
The MHRA released a summary of letters and notifications sent to healthcare professionals in April 2024 regarding medicines, medical devices, and two new Device Safety Information pages.
Regulatory Updates
Aug 25, 2026•1 min read
MHRA Summary of Recent Medicine and Device Safety Letters
The MHRA has released a summary of recent letters and notifications sent to healthcare professionals about medicines and medical devices.
Regulatory Updates
Aug 25, 2026•1 min read
MHRA Issues New Safety Measures: Topiramate Contraindicated in Pregnancy
Topiramate is now contraindicated in pregnancy and in women of childbearing potential unless a Pregnancy Prevention Programme is followed, per MHRA review.
Regulatory Updates
Aug 25, 2026•1 min read
MHRA Drug Safety Update: June 2024 Letters and Notifications
The MHRA released a summary of recent letters and notifications sent to healthcare professionals about medicines and medical devices.
Regulatory Updates
Aug 25, 2026•1 min read
MHRA warns Epimax ointments may cause ocular surface toxicity if applied to face
MHRA advises against prescribing Epimax Ointment or Epimax Paraffin‑Free Ointment for facial use due to reports of eye injury.
Regulatory Updates
Aug 25, 2026•1 min read
MHRA August 2024 Drug Safety Update: Summary of Letters and Recalls
The MHRA released a summary of letters and notifications sent to healthcare professionals in August 2024 regarding medicines and medical devices.
Regulatory Updates
Aug 25, 2026•1 min read
MHRA Drug Safety Update: September 2024 Letters & Recalls
MHRA released a summary of recent letters and notifications to healthcare professionals concerning medicines and medical devices for September 2024.
Regulatory Updates
Aug 25, 2026•1 min read
MHRA advises blood pressure monitoring for bromocriptine patients
MHRA safety review recommends blood pressure monitoring for patients on bromocriptine following a Yellow Card report.
Regulatory Updates
Aug 25, 2026•1 min read
MHRA reminds HCPs to discuss GLP‑1RA side effects with patients
Healthcare professionals should inform patients of common and serious side effects of GLP‑1 receptor agonists.